Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase-IIIb Individually Randomized, Placebo-controlled Trial on Safety of RSVA/B-preF Vaccine in Pregnant Women and Efficacy Against Severe RSV-associated Lower Respiratory Tract Infection in Infants

NCT06955728 is registered in ClinicalTrials.gov with University of Witwatersrand, South Africa as lead sponsor.

NCT NCT06955728
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06955728 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase-IIIb Individually Randomized, Placebo-controlled Trial on Safety of RSVA/B-preF Vaccine in Pregnant Women and Efficacy Against Severe RSV-associated Lower Respiratory Tract Infection in Infants
Lead sponsor
University of Witwatersrand, South Africa
Phase
Phase 3
Overall status
Recruiting
Start date
September 3, 2025
Completion date
February 29, 2028
Enrollment
13,000 (estimated)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

preterm labour, rsv immunisation, rsv infections